Hotspot debuts with $45M to find, drug natural allosteric sites

HotSpot Therapeutics Inc. (Cambridge, Mass.) emerged from stealth on July 17 with a $45 million series A round co-led by Atlas Venture and Sofinnova Partners.

Read the full 259 word article

User Sign In